Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

Retrospective study in the 3 intensive care units of the Brest Teaching Hospital (France) during a 18-months period (June 2014 -December 2015) to study the independent association between hypophosphatemia and 90-day mortality.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypophosphatemia Infection Infections Metabolic Diseases Nutritional and Metabolic Diseases Phosphorus Metabolism Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest

Brest, 29609, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Blood stream infection

Exclusion criteria

Less than 18 years old

Treatment and study plan

Primary outcomes

90-day mortality

Time frame: 90 days since the first blood stream infection in ICU

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Evaluation of Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

Acronym: PORPOISE-REA

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: May 18, 2018
Registry last updated: May 18, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed